Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
From the Editor

Potential systemic benefits of shocking or blocking nerves

Brian F. Mandell, MD, PhD
Cleveland Clinic Journal of Medicine March 2022, 89 (3) 119-120; DOI: https://doi.org/10.3949/ccjm.89b.03022
Brian F. Mandell
Roles: Editor in Chief
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Find this author on Cleveland Clinic
  • Article
  • Info & Metrics
  • PDF
Loading

Embedded Image

While hormone therapy is demonstrably effective for vasomotor symptoms for the vast majority of perimenopausal and postmenopausal women, for some patients it is not an acceptable choice. In this issue of the Journal, Lee et al1 discuss stellate ganglion block (SGB), the guided percutaneous injection of anesthetic to relieve vasomotor symptoms, as an alternative in women for whom estrogen replacement is not a good option or has failed along with other approaches to provide adequate symptom control.

Studies supporting the efficacy of SGB are fairly small and of short duration. The reported efficacy varies, perhaps indicating a need for patient selection criteria, and perhaps indicating a significant dependence on the skill of the proceduralist. My takeaway is that this is a potential niche therapy for women with few options to control their significant vasomotor symptoms and improve quality of life.

Digging deeper into the topic of nerve manipulation therapies brings to light fascinating heretofore fringe literature on this and other conceptually related approaches of neuromodulation. There are reports of SGB benefitting patients with various upper extremity and facial pain syndromes including migraine. Preclinical research has suggested that nerve fibers connect this sympathetic nerve way station to parts of the brain including the hypothalamus, potentially influencing the impact of hormones on the stress response and the immune system. Isolated reports suggest benefit of SGB in diverse syndromes including posttraumatic stress disorder, dysautonomia, and long-haul COVID-19. If true, the mechanism is likely far more complex than simply blocking regional sympathetic outflow to modulate regional vasoconstriction and dilation. SGB is used to treat other conditions and is featured on the websites of several medical centers.

What has really caught my attention is the expanding research on controlled regional neuromodulation and its impact on systemic physiology and inflammation. Using electrical current to directly affect function of nerve and muscle is well accepted and at least conceptually understandable (eg, electroconvulsive therapy for depression, deep brain stimulation for Parkinson disease, cardiac pacemaker and defibrillator input for heart rhythm control). It is far less readily conceptualized how nerve stimulation can exert effects on systemic inflammation and the immune response.

But fascinating are the studies on stimulating (not blocking as is done with SGB) the vagal nerve, which can be done percutaneously. Several distinct animal models, involving different organs and inflammatory triggers, have been used to demonstrate systemic anti-inflammatory effects stemming from stimulation of the vagal nerve and some of its branches. One hypothesis with some experimental support explains this effect via vagal stimulation of the splenic nerve, which causes acetylcholine release in the spleen. The acetylcholine binds to receptors on macrophages and likely other cells, resulting in downregulation of inflammatory cytokines such as tumor necrosis factor, and also in altered cell circulation.2

A recent open-label study3 in human patients with rheumatoid arthritis receiving percutaneous vagal nerve stimulation generated promising (though very preliminary) beneficial results using well-accepted clinical, laboratory, and imaging techniques. Larger studies in patients with rheumatoid arthritis are ongoing. A seemingly successful site for percutaneous stimulation is the external ear, where there are branches of the vagal nerve, making this a far more accessible and acceptable approach compared with direct activation of the vagal trunk as used in some animal studies.

While I am not yet ready to accept that the electromagnetic aura of body magnets and copper bracelets may replace methotrexate, it is provocative to wonder whether controlled neuromodulation may in the future provide a useful nonpharmacologic adjunct to the treatment of pain and inflammation. A better understanding of it may even help explain some of the beneficial effects of acupuncture, a procedure that has also in some studies reduced menopausal hot flashes.

  • Copyright © 2022 The Cleveland Clinic Foundation. All Rights Reserved.

References

  1. ↵
    1. Lee YS,
    2. Wie C,
    3. Pew S,
    4. Kling JM
    . Stellate ganglion block as a treatment for vasomotor symptoms: clinical application. Cleve Clin J Med 2022: 89(3):147–153. doi:10.3949/ccjm.89a.21032
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Tynan A,
    2. Brines M and
    3. Chavan S
    . Control of inflammation using non-invasive neuromodulation: past, present, and promise. Int Immunol 2022; 34(2):119–128. doi:10.1093/intimm/dxab073
    OpenUrlCrossRef
  3. ↵
    1. Marsal S,
    2. Corominas H,
    3. de Augustin JJ, et al
    . Non-invasive vagus nerve stimulation for rheumatoid arthritis: a proof-of-concept study. Lancet Rheumatol 2021: 3(4)e262–e269. https://doi.org/10.1016/S2665-9913(20)30425-2
    OpenUrlCrossRef
PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 89 (3)
Cleveland Clinic Journal of Medicine
Vol. 89, Issue 3
1 Mar 2022
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Potential systemic benefits of shocking or blocking nerves
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Potential systemic benefits of shocking or blocking nerves
Brian F. Mandell
Cleveland Clinic Journal of Medicine Mar 2022, 89 (3) 119-120; DOI: 10.3949/ccjm.89b.03022

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Potential systemic benefits of shocking or blocking nerves
Brian F. Mandell
Cleveland Clinic Journal of Medicine Mar 2022, 89 (3) 119-120; DOI: 10.3949/ccjm.89b.03022
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
    • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • The gift of lasting immunity
  • Psychedelics in the medical toolbox?
  • All sulfa drugs are not created equal
Show more From the Editor

Similar Articles

Subjects

  • Dermatology
  • Drug Therapy
  • Endocrinology
  • Geriatrics
  • Infectious Diseases
  • Men's Health
  • Neurology
  • Preventive Care
  • Rheumatology
  • Women's Health

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire